Related Experiment Video
Updated: Jun 16, 2026
05:46
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
HIV-1 integrase inhibitors: 2007-2008 update
Kavya Ramkumar1, Erik Serrao, Srinivas Odde
1Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, School of Pharmacy, 1985 Zonal Avenue, Los Angeles, California 90089, USA.
Medicinal Research Reviews
|February 6, 2010
Summary
HIV-1 integrase inhibitors represent a new generation of antiretroviral drugs. Recent advances in structural biology have spurred the development of novel HIV-1 integrase inhibitor design strategies.
Area of Science:
- * Virology and Drug Discovery
- * Medicinal Chemistry and Pharmacology
Background:
- * HIV-1 integrase (IN) is a critical enzyme for viral replication and a key target for antiretroviral therapy.
- * The approval of raltegravir, the first integrase inhibitor, validated its therapeutic potential.
- * Previous research has established the foundation for developing novel IN inhibitors.
Purpose of the Study:
- * To review recent advancements in HIV-1 integrase inhibitor design between 2007 and 2008.
- * To highlight novel strategies for targeting HIV-1 integrase.
- * To discuss the impact of structural biology on inhibitor development.
Main Methods:
- * Comprehensive literature review of studies published from 2007 to 2008.
- * Analysis of drug design strategies and structural biology insights.
- * Identification of key developments in HIV-1 integrase inhibitor research.
Main Results:
- * Raltegravir's approval confirmed the viability of integrase inhibitors.
- * Several potent HIV-1 integrase inhibitors were identified.
- * New approaches targeting IN multimerization and cofactor interactions emerged.
Conclusions:
- * HIV-1 integrase remains a promising target for antiretroviral drug development.
- * Advances in structural biology are crucial for designing next-generation inhibitors.
- * The field is rapidly evolving with new therapeutic strategies.
Related Concept Videos
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
02:33Retroviruses
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...